Advertisement

Ads Placeholder
Loading...

Scilex Holding Company

SCLX•NASDAQ
Healthcare
Drug Manufacturers - General
$7.44
$0.53(7.67%)
U.S. Market opens in 3h 58m

Scilex Holding Company (SCLX) Stock Overview

Explore Scilex Holding Company’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap63.6M
P/E Ratio-0.23
EPS (TTM)$-40.46
ROE1.81%
Fundamental Analysis

AI Price Forecasts

1 Month$-2.10
3 Months$11.45
1 Year Target$22.10

SCLX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Scilex Holding Company (SCLX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of A, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 46.68, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $22.10.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.23 and a market capitalization of 63.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
7.67%
5-Day Change
8.30%
1-Month Change
-17.06%
3-Month Change
-43.16%
6-Month Change
-52.85%
Year-to-Date (YTD) Change
-43.16%
1-Year Change
-25.30%
3-Year Change
-97.39%
5-Year Change
-97.85%
All-Time (Max) Change
-97.84%

Contact Information

https://www.scilexholding.com
650-516-4310
960 San Antonio Road, Palo Alto, CA, 94303

Company Facts

1,150 Employees
IPO DateMar 5, 2021
CountryUS
Actively Trading

Frequently Asked Questions